Start / PharmaTalkRadio / The current status of patient centricity in medicine development

PharmaTalkRadio

The Current Status of Patient Centricity in Medicine Development

26 min • 14 maj 2025

Summary:
This podcast focuses on the current state of patient centricity within the biopharmaceutical industry, how it's being implemented, operationalized and scaled within organizations, and showing the tangible value of engaging patients.

Dr Matthew Reaney, Scientific Lead, Patient-Centered Solutions at IQVIA, speaks with Dr Anthony Yanni, SVP, Head of Patient Centricity at Astellas, to share their experiences, what they've seen in patient centricity gains, standing up patient centricity functions and proving the business case for doing so.

For more information, go to theconferenceforum.org.

Senaste avsnitt

De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing

12 augusti | 28 min

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

12 augusti | 28 min

Directors' Talk DPHARM 2025 - AI Sessions; Part III

25 juli | 6 min

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

25 juli | 20 min

Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

25 juli | 29 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00